A Single-Center Cohort Study on Cutaneous Manifestations of Anti-Nuclear Matrix Protein 2 Antibody-Positive Dermatomyositis.
Anti-nuclear matrix protein 2 (NXP2) is an autoantibody that has been more commonly identified in juvenile dermatomyositis (JDM) than in adult dermatomyositis (DM).1 Anti-NXP2 positivity may portend an increased risk of underlying malignancy in adult patients with myositis1 . However, the scope of the cutaneous manifestations in anti-NXP2-positive patients is less clear. Our study aims to clarify the characteristics of the cutaneous symptoms seen in adult anti-NXP2-positive DM.